ERBB2 and lung adenocarcinoma: This work was presented, in part, at the 15th World Conference on Lung Cancer, October 27th-30th 2013, Sydney, New South Wales, Australia (Oral Presentation: MO10.03: Decreased KRAS and increased HER2 OR PI3K mutations prevalence in the French emigrant population from African continent in lung adenocarcinoma metastatic cancer.